100 related articles for article (PubMed ID: 16793718)
1. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor.
Bruserud Ø; Foss B; Ulvestad E; Hervig T
Platelets; 1998; 9(6):352-8. PubMed ID: 16793718
[TBL] [Abstract][Full Text] [Related]
2. Effects of normal platelets on proliferation and constitutive cytokine secretion by human acute myelogenous leukaemia blasts.
Bruserud Ø; Foss B; Hervig T
Platelets; 1997; 8(6):397-404. PubMed ID: 16793674
[TBL] [Abstract][Full Text] [Related]
3. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
4. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud O
Eur J Haematol; 2001 Jun; 66(6):365-76. PubMed ID: 11488935
[TBL] [Abstract][Full Text] [Related]
7. IL-4, IL-10 and IL-13 in acute myelogenous leukemia.
Bruserud O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844
[TBL] [Abstract][Full Text] [Related]
8. Platelet functions and clinical effects in acute myelogenous leukemia.
Foss B; Bruserud O
Thromb Haemost; 2008 Jan; 99(1):27-37. PubMed ID: 18217131
[TBL] [Abstract][Full Text] [Related]
9. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
Bruserud O
Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
[TBL] [Abstract][Full Text] [Related]
10. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
Glenjen NI; Hatfield K; Bruserud Ø
Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
[TBL] [Abstract][Full Text] [Related]
11. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
12. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
Foss B; Mentzoni L; Bruserud O
J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
[TBL] [Abstract][Full Text] [Related]
13. Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia.
Foss B; Ulvestad E; Hervig T; Bruserud Ø
Int J Cancer; 2002 Jan; 97(1):106-14. PubMed ID: 11774251
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
Glenjen N; Ersvaer E; Ryningen A; Bruserud Ø
Int J Cancer; 2004 Oct; 111(6):858-67. PubMed ID: 15300797
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 (IL4), IL10 and IL13 Inhibit in vitro Cytokine Secretion by Acute Myelogenous Leukemia Blasts in the Presence of Exogenous Hematopoietic Growth Factors.
Bruserud Ø
Hematology; 1998; 3(6):443-50. PubMed ID: 27420331
[TBL] [Abstract][Full Text] [Related]
16. Expression and release of adhesion molecules by human acute myelogenous leukemia blasts.
Bruserud O; Ulvestad E
Leuk Res; 1999 Feb; 23(2):149-57. PubMed ID: 10071130
[TBL] [Abstract][Full Text] [Related]
17. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
[TBL] [Abstract][Full Text] [Related]
18. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.
Hatfield K; Ryningen A; Corbascio M; Bruserud O
Int J Cancer; 2006 Nov; 119(10):2313-21. PubMed ID: 16921487
[TBL] [Abstract][Full Text] [Related]
19. 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.
Vincent C; Fiancette R; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2008 Nov; 32(11):1756-62. PubMed ID: 18561999
[TBL] [Abstract][Full Text] [Related]
20. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
